Ani Zlatareva-Petrova

Research Areas

HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis

Most-Cited Works

• → Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients(2017)46 cited